These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19876704

  • 1. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
    Monzawa S, Adachi S, Suzuki K, Hirokaga K, Takao S, Sakuma T, Hanioka K.
    Ann Nucl Med; 2009 Dec; 23(10):855-61. PubMed ID: 19876704
    [Abstract] [Full Text] [Related]

  • 2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 3. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
    Groheux D, Moretti JL, Baillet G, Espie M, Giacchetti S, Hindie E, Hennequin C, Vilcoq JR, Cuvier C, Toubert ME, Filmont JE, Sarandi F, Misset JL.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):695-704. PubMed ID: 18436392
    [Abstract] [Full Text] [Related]

  • 4. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
    Zhao TT, Li JG, Li YM.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):206-9. PubMed ID: 17649638
    [Abstract] [Full Text] [Related]

  • 5. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S.
    Eur Urol; 2009 Aug 01; 56(2):339-45. PubMed ID: 19477581
    [Abstract] [Full Text] [Related]

  • 6. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.
    Cancer; 2009 Dec 01; 115(23):5470-80. PubMed ID: 19739235
    [Abstract] [Full Text] [Related]

  • 7. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
    Lovrics PJ, Chen V, Coates G, Cornacchi SD, Goldsmith CH, Law C, Levine MN, Sanders K, Tandan VR.
    Ann Surg Oncol; 2004 Sep 01; 11(9):846-53. PubMed ID: 15313737
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
    Liu BJ, Dong JC, Xu CQ, Zuo CT, Le JJ, Guan YH, Zhao J, Wu JF, Duan XH, Cao YX.
    Chin Med J (Engl); 2009 Aug 05; 122(15):1749-54. PubMed ID: 19781319
    [Abstract] [Full Text] [Related]

  • 9. Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
    Kubota K, Murakami K, Inoue T, Itoh H, Saga T, Shiomi S, Hatazawa J.
    Ann Nucl Med; 2011 Dec 05; 25(10):777-86. PubMed ID: 21901365
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E, Gauthier H, Querleu D, Ferron G, Zerdoud S, Morice P, Uzan C, Lumbroso S, Lecuru F, Bats AS, Ghazzar N, Bannier M, Houvenaeghel G, Brenot-Rossi I, Narducci F.
    Ann Surg Oncol; 2011 Aug 05; 18(8):2302-9. PubMed ID: 21347790
    [Abstract] [Full Text] [Related]

  • 11. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 12. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 01; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 13. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [Abstract] [Full Text] [Related]

  • 14. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K.
    Rofo; 2002 Jun 01; 174(6):714-20. PubMed ID: 12063600
    [Abstract] [Full Text] [Related]

  • 15. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
    Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.
    Eur J Radiol; 2010 Feb 01; 73(2):294-9. PubMed ID: 19181468
    [Abstract] [Full Text] [Related]

  • 16. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.
    Acta Radiol; 2015 Aug 01; 56(8):917-23. PubMed ID: 25013091
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y, Kubota K, Katayama T, Toriihara A, Shibuya H.
    Eur J Surg Oncol; 2013 Jan 01; 39(1):26-30. PubMed ID: 23122913
    [Abstract] [Full Text] [Related]

  • 18. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
    Taira N, Ohsumi S, Takabatake D, Hara F, Takashima S, Aogi K, Takashima S, Inoue T, Sugata S, Nishimura R.
    Jpn J Clin Oncol; 2009 Jan 01; 39(1):16-21. PubMed ID: 18997183
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
    An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, Kim KS, Jung YS, Yim H.
    Nuklearmedizin; 2014 Jan 01; 53(3):89-94. PubMed ID: 24220324
    [Abstract] [Full Text] [Related]

  • 20. A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy.
    Fujiuchi N, Saeki T, Takeuchi H, Sano H, Takahashi T, Matsuura K, Shigekawa T, Misumi M, Nakamiya N, Okubo K, Osaki A, Sakurai T, Matsuda H.
    Breast Cancer; 2011 Apr 01; 18(2):141-4. PubMed ID: 19554397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.